NISA INVESTMENT ADVISORS, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$77,785
-96.9%
2,460
-96.1%
0.00%
-94.7%
Q2 2023$2,546,711
+3441401.4%
62,450
+3054.0%
0.02%
+1800.0%
Q1 2023$74
+8.8%
1,980
+1.0%
0.00%0.0%
Q4 2022$68
-99.9%
1,960
-5.4%
0.00%0.0%
Q3 2022$109,000
+38.0%
2,072
+36.3%
0.00%0.0%
Q2 2022$79,000
-41.9%
1,520
-18.7%
0.00%0.0%
Q1 2022$136,000
-53.4%
1,870
-39.5%
0.00%
-50.0%
Q4 2021$292,000
-91.8%
3,090
-88.3%
0.00%
-90.9%
Q3 2021$3,554,000
+619.4%
26,491
+768.6%
0.02%
+633.3%
Q2 2021$494,000
+101.6%
3,0500.0%0.00%
+50.0%
Q1 2021$245,000
+47.6%
3,0500.0%0.00%
+100.0%
Q4 2020$166,000
+295.2%
3,050
+45.2%
0.00%
Q3 2020$42,000
-91.4%
2,100
-87.7%
0.00%
-100.0%
Q3 2018$489,000
+123.3%
17,100
+113.8%
0.00%
+100.0%
Q2 2018$219,000
+29.6%
8,0000.0%0.00%0.0%
Q1 2018$169,000
+9.7%
8,0000.0%0.00%0.0%
Q4 2017$154,000
-22.6%
8,0000.0%0.00%0.0%
Q3 2017$199,000
+48.5%
8,000
+1.3%
0.00%0.0%
Q2 2017$134,0007,9000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders